ResearchLRMR
LRMR: FY25 Deep Dive
Published 1 min read
Larimar Therapeutics FY25 at $0M. NI $-166M; EPS $-2.27.
LRMR: FY25 Deep Dive
FY25 revenue $0M; OI $-172M; NI $-166M; EPS $-2.27.
Larimar Therapeutics FY25 (Dec 31, 2025) at $0M revenue. OpInc $-172M; NI $-166M; EPS $-2.27. Biotech.
